Abbott invites you to their event

EASD 2023 Symposium: Busting Myths of Glucose Sensing Technology and Rethinking the Treatment Limits

About this event

Watch our debate moderated by journalist and TV presenter Stephen Dixon.

  • Myth #1: Glucose sensing technology is too complex for my practice and patients!
  • Myth #2: Only patients on intensive insulin treatment benefit from glucose sensing technology!
  • Myth #3: SMBG is enough for good glucose control and prevention of acute events.

Watch a robust discussion as we break down myths on glucose sensing technology – online now!

This symposium took place at EASD 2023 on October 3rd in Hamburg. After registering, you will receive an email with a link to watch the event on-demand, whenever you have time.

All rights reserved. The sensor housing, FreeStyle, Libre, and related brand marks are marks of Abbott.© 2023 Abbott. ADC-77505 v2.0

Hosted by

  • External speaker
    E
    Dr. Boris Klanger (SE)

    Consultant physician and Head of Clinic LäkarGruppen, Västerås, Sweden

  • External speaker
    E
    Prof. Ramzi Ajjan (UK)

    Professor of Metabolic Medicine, Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds and Leeds Teaching Hospitals Trust

  • External speaker
    E
    Stephen Dixon (UK)

    Journalist and TV presenter, living with type 1 diabetes for 31 years

  • External speaker
    E
    Dr. Clare Hambling (UK)

    General Practitioner & GPwSI Diabetes Bridge Street Surgery Norfolk

  • External speaker
    E
    Prof. Maddalena Lettino (IT)

    Director of the Unit of Clinical Cardiology and of the Cardiothoracovascular Department of the San Gerardo Hospital in Monza

  • External speaker
    E
    Dr. Markus Menzen (DE)

    Senior consultant and Head of Department, Division of Internal Medicine, Department of Endocrinology and Diabetology, Community Hospital Bonn

  • External speaker
    E
    Dr. Elina Pimiä (FI)

    Chief Medical Officer Finnish Diabetes Association / Head of Diabetes Outpatient Clinic, Wellbeing Services of County Pirkanmaa

Abbott

At Abbott, we’re focused on making breakthrough technology accessible and approachable for all. Our sensing technology has revolutionized how people monitor glucose and provides doctors with more data for better informed treatment decisions